| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |